Tianjin Taiding, Defu-Backed Wenzhou Kangning Hospital Seeks $88M HK IPO

Wenzhou Kangning Hospital Co., Ltd., a Chinese psychiatric healthcare group backed by Tianjin Taiding Investment Co., Ltd. and Shenzhen Defu Fund Management Co., Ltd., is seeking to raise as much as HK$680 million (US$88 million) in an initial public offering in Hong Kong, according to a securities filing.

The company is planning to sell 17.6 million new shares at HK$32.1 to HK$38.7 apiece. It plans to determine a final price on Friday. Its shares will begin trading on the Hong Kong Stock Exchange on November 20.

The company has secured OrbiMed Advisors, LLC, a healthcare-focused private equity firm with US$15 billion under management, and Hong Kong-based Prime Capital Management as cornerstone investors to take around 40% of the offering.

Founded in 1996, Wenzhou Kangning Hospital focuses on psychiatric medical treatment. It currently operates six hospitals and clinics, and is in the process of adding more hospitals.

China Money Network Subscription
Caishen.Co - Primary Data for China Secondary Investment and Stock Markets